Journal profile · Neurosciences
Current Alzheimer Research
ISSN 1567-2050 · eISSN 1875-5828 · Bentham Science Publishers B.V. · NETHERLANDS · Bimonthly · Founded 2004
Current Alzheimer Research: CAS Zone 4 · Medicine (2025 upgraded edition); impact factor 2.31; hybrid open access; median 77 days to acceptance (86 articles, last 24 months); community-reported acceptance: moderate; 77 articles in 2025; indexed in SCIE and Scopus.
Scope
Aims, scope and focus
Current Alzheimer Research is published by Bentham Science Publishers B.V. and is in Zone 4 of Medicine in the CAS Journal Ranking (2025 upgraded edition). By OpenAlex counts of its recent articles, its largest topics are Alzheimer's disease research and treatments, Dementia and Cognitive Impairment Research and Cholinesterase and Neurodegenerative Diseases, together about 56.5% of its articles. Its main subfields are Neurology. (generated from OpenAlex topic counts and CAS ranking data)
Current Alzheimer Research publishes peer-reviewed frontier review, research, drug clinical trial studies and letter articles on all areas of Alzheimer’s disease. This multidisciplinary journal will help in understanding the neurobiology, genetics, pathogenesis, and treatment strategies of Alzheimer’s disease. The journal publishes objective reviews written by experts and leaders actively engaged in research using cellular, molecular, and animal models. The journal also covers original articles on recent research in fast emerging areas of molecular diagnostics, brain imaging, drug development and discovery, and clinical aspects of Alzheimer’s disease. Manuscripts are encouraged that relate to the synergistic mechanism of Alzheimer's disease with other dementia and neurodegenerative disorders. Book reviews, meeting reports and letters-to-the-editor are also published. The journal is essential reading for researchers, educators and physicians with interest in age-related dementia and Alzheimer’s disease. Current Alzheimer Research provides a comprehensive 'bird's-eye view' of the current state of Alzheimer's research for neuroscientists, clinicians, health science planners, granting, caregivers and families of this devastating disease.
Source: LetPub
Research area (LetPub): Neurosciences
Main research topics OpenAlex counts of recent articles; shares are approximate
- Alzheimer's disease research and treatmentsMedicine29.7%
- Dementia and Cognitive Impairment ResearchMedicine17.2%
- Cholinesterase and Neurodegenerative DiseasesMedicine9.6%
- Neurological Disease Mechanisms and TreatmentsNeuroscience4.1%
- Neuroinflammation and Neurodegeneration MechanismsNeuroscience3.8%
- Computational Drug Discovery MethodsComputer Science3.6%
- Tryptophan and brain disordersNeuroscience3.6%
- 14-3-3 protein interactionsBiochemistry, Genetics and Molecular Biology3.3%
Rankings & indexing
CAS ranking and database indexing
CAS Journal Ranking
CAS Journal Ranking, upgraded edition (March 2025)Medicine Zone 4
| Level | Category | Zone |
|---|---|---|
| Major | Medicine | Zone 4 |
| Minor | Clinical Neurology | Zone 4 |
| Minor | Neurosciences | Zone 4 |
Top journal: noReview journal: no
CAS Xinrui Journal Ranking (March 2026)Medicine Zone 4
| Level | Category | Zone |
|---|---|---|
| Major | Medicine | Zone 4 |
| Minor | Clinical Neurology | Zone 4 |
| Minor | Neurosciences | Zone 4 |
Top journal: noReview journal: not marked
CAS Journal Ranking, previous upgraded edition (December 2023)Medicine Zone 4
| Level | Category | Zone |
|---|---|---|
| Major | Medicine | Zone 4 |
| Minor | Clinical Neurology | Zone 4 |
| Minor | Neurosciences | Zone 4 |
Top journal: noReview journal: no
Database indexing
SCIEScopusLetPub
International journal early-warning lists: not listed in any editionLetPub
Editions, and major and minor categories, are shown separately and never merged into one zone; check which edition your institution uses before you submit or report.
Metrics
Impact metrics and publication volume
Impact
- Impact factor
- 2.31LetPub ·
- CiteScore 2026-06
- 3.5LetPub ·
- SJR 2026-06
- 0.55LetPub ·
- SNIP 2026-06
- 0.47LetPub ·
- h-index
- 74LetPub ·
- h-index
- 119OpenAlex ·
- i10-index
- 1,476OpenAlex ·
- 2-year mean citedness
- 2.05OpenAlex ·
- Self-citation rate
- 8.3%LetPub ·
- Share of gold OA articles
- 5.66%LetPub ·
Volume
- Articles per year
- 85LetPub ·
Articles by year OpenAlex count · 2,327 in total · the current year is incomplete
| Year | Articles | Open access | Citations |
|---|---|---|---|
| 2026 | 87 | 3 | 29 |
| 2025 | 77 | 5 | 133 |
| 2024 | 60 | 9 | 298 |
| 2023 | 83 | 13 | 545 |
| 2022 | 77 | 16 | 634 |
| 2021 | 142 | 31 | 1,625 |
Sources count differently and were observed at different times, so each source's own value is kept; "publisher" marks figures from the journal's website.
Review & acceptance
Review time and acceptance
Review time from article dates manuscript dates registered with Crossref · to
77 daysMedian, submission to acceptance · P25–P75 60 days – 103 days
- Acceptance to online
- median 120 days (86 articles)
- Submission to online
- median 199 days
- Sample
- 86 articles with submission and acceptance dates (192 in the window); the latest was accepted on
Only articles that were accepted and published are counted, not the time spent on rejected manuscripts, so this usually runs longer than a publisher's "time to first decision".
Other sources
- Average review time (community reports)
- 4–8 weeksLetPub ·
- Average acceptance (community reports)
- ModerateLetPub ·
Community reports come from authors' own submissions (confidence 0.5) and are not a promise from the journal; for publisher figures, the journal's own definitions apply.
Fees & open access
APC and open-access policy
Hybrid open accessLetPub
A subscription journal in which authors can pay to publish their article open access.
No source has fee information yet; check the journal's website.
A hybrid journal charges the APC only when the author chooses open access; publishing under the subscription model is usually free.
The journal's website is authoritative for fees; sources were observed at different times and each keeps its own value, without averaging.
Profile
Publication details and official links
- Publisher
- Bentham Science Publishers B.V.
- Country or region
- NETHERLANDS
- Language
- English
- Frequency
- Bimonthly
- Founded
- 2004
- ISSN
- 1567-2050
- Electronic ISSN
- 1875-5828
- Official links
- Journal homepage ↗OpenAlex
- Submission system ↗LetPub
FAQ
Frequently asked questions about Current Alzheimer Research
What CAS zone is Current Alzheimer Research in?
In the 2025 upgraded edition of the CAS Journal Ranking, Current Alzheimer Research is in Zone 4 of Medicine, and in Zone 4 of the minor category Clinical Neurology / Neurosciences. In the 2026 Xinrui edition it is in Zone 4 of Medicine. Zones from different editions, and from major and minor categories, are not interchangeable.
What is the impact factor of Current Alzheimer Research?
The latest impact factor listed by LetPub is 2.31; CiteScore 3.5, h-index 119.
How long does peer review take at Current Alzheimer Research?
Based on the dates recorded on 86 articles published between October 2024 and October 2026 (the last 24 months), the median time from submission to acceptance is 77 days (interquartile range 60–103 days); authors report an average review time of 4–8 weeks; the community-reported acceptance is “Moderate”. Article statistics cover accepted papers only, publisher figures follow the journal's own definitions, and community reports come from authors' own submissions; none is a promise from the journal.
Which databases index Current Alzheimer Research?
According to LetPub and DOAJ records, Current Alzheimer Research is indexed in SCIE and Scopus.
Is Current Alzheimer Research open access, and what is the APC?
Current Alzheimer Research is a hybrid journal. Fee information is not available yet; check the journal's website.
Sources and updates
The facts on this page come from LetPub, OpenAlex; every figure is tagged with its source and the date it was observed, and conflicting values are kept per source. LetPub source page: view ↗ (archived 2026-08-26). Last updated: .